News

BÜHLMANN posters at WorldLab 2024 Dubai!

From gastroenterology to neuroimmunology, read the newest developments from BÜHLMANN in our posters presented at the WorldLab 2024!

Read more

Highlights from ECCO 2024

During ECCO 2024, held from February 21st to 24th, international IBD specialists came to Stockholm to present the latest news in IBD care. In this setting, our colleagues Oliver Dähn and Christian Reinhard had the privilege of presenting the following two posters:   Poster 1: P437 - Feasibility study of a Point-of-Care assay for rapid
Read more

Successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay

Interview with the Dr. Risch AIOS-Team about the successful introduction of the Seegene STARlet-AIOS fully automated system with the AllplexTM STI Essential Assay, AllplexTM Genital Ulcer Assay and the AllplexTM HPV28 Genotyping Assay

Read more

Succesful implementation of Quantum Blue­® Adalimumab and Anti-Adalimumab

Learn how Dr. Bernard Royer from the Clinical Pharmacology and Toxicology Service at the Centre Hospitalier Universitaire de Besançon, France, significantly improved turnaround time and streamlined testing processes by adopting the BÜHLMANN therapeutic drug monitoring assays.

Read more